1. BRAF Status in Papillary Microcarcinomas of the Thyroid Gland: a Brief Review
    Antonio Ieni et al, 2019, Current Molecular Medicine CrossRef

  2. Predictive Factors for Level V Lymph Node Metastases in Papillary Thyroid Carcinoma with BRAFV600E Mutation and Clinicopathological Features


    Gui-you Li et al, 2020, Cancer Management and Research CrossRef
  3. A comprehensive prediction model for central lymph node metastasis in papillary thyroid carcinoma with Hashimoto’s thyroiditis: BRAF may not be a valuable predictor
    Yanwei Chen et al, 2024, Frontiers in Endocrinology CrossRef
  4. Improved guidance is needed to optimise diagnostics and treatment of patients with thyroid cancer in Europe
    Christelle de la Fouchardière et al, 2023, Endocrine CrossRef
  5. Comparative efficiency of differential diagnostic methods for the identification of BRAF V600E gene mutation in papillary thyroid cancer (Review)
    Qian Liu et al, 2024, Experimental and Therapeutic Medicine CrossRef
  6. Pathological Factors Affecting DNA Quality in BRAF, EGFR, and KRAS Gene Molecular Tests
    Hyon-Goo Yun et al, 2020, The Korean Journal of Clinical Laboratory Science CrossRef
  7. The evolving landscape of tissue‐agnostic therapies in precision oncology
    Vivek Subbiah et al, 2024, CA: A Cancer Journal for Clinicians CrossRef
  8. Initial Management of BRAF V600E-Variant Anaplastic Thyroid Cancer
    Sarah Hamidi et al, 2024, JAMA Oncology CrossRef
  9. The Role of BRAF Gene in Cancer: Literature Review and Future Directions
    null Ricardo Hsieh, 2020, Journal of Cancer Research Updates CrossRef
  10. Electrochemical biosensors for analysis of DNA point mutations in cancer research
    Katerina Ondraskova et al, 2023, Analytical and Bioanalytical Chemistry CrossRef